NATIONAL BIOTECHNOLOGY MONTH,
2000
BY THE PRESIDENT OF THE UNITED
STATES OF AMERICA
A PROCLAMATION
As we stand at the dawn
of a new century, we recognize the enormous
potential that biotechnology
holds for improving the quality of life here
in the United States and around
the world. These technologies, which draw
on our understanding of the
life sciences to develop products and solve
problems, are progressing
at an exponential rate and promise to make
unprecedented contributions
to public health and safety, a cleaner
environment, and economic
prosperity.
Today,
a third of all new medicines in development are based on
biotechnology. Designed
to attack the underlying cause of an illness, not
just its symptoms, these medicines
have tremendous potential to provide not
only more effective treatments,
but also cures. With improved
under-standing of cellular
and genetic processes, scientists have opened
exciting new avenues of research
into treatments for devastating diseases
-- like Parkinson's and Alzheimer's,
diabetes, heart disease, AIDS, and
cancer -- that affect millions
of Americans. Biotechnology has also given
us several new vaccines, including
one for rotavirus, now being tested
clinically, that could eradicate
an illness responsible for the deaths of
more than 800,000 infants
and children each year.
The
impact of biotechnology is far-reaching. Bioreme-diation
technologies are cleaning
our environment by removing toxic substances from
contaminated soils and ground
water. Agricultural biotechnology reduces
our dependence on pesticides.
Manufacturing processes based on
biotechnology make it possible
to produce paper and chemicals with less
energy, less pollution, and
less waste. Forensic technologies based on our
growing knowledge of DNA help
us exonerate the innocent and bring criminals
to justice.
The
biotechnology industry is also improving lives through its
substantial economic impact.
Biotechnology has stimulated the creation and
growth of small businesses,
generated new jobs, and encouraged agricultural
and industrial innovation.
The industry currently employs more than
150,000 people and invests
nearly $10 billion a year on research and
development.
Recognizing
the extraordinary promise and benefits of this enterprise,
my Administration has pursued
policies to foster biotechnology innovations
as expeditiously and prudently
as possible. We have supported steady
increases in funding for basic
scientific research at the National
Institutes of Health and other
science agencies; accelerated the process
for approving new medicines
to make them available as quickly and safely as
possible; encouraged private-sector
research investment and small business
development through tax incentives
and the Small Business Innovation
Research program; promoted
intellectual property protection and open
international markets for
biotechnology inventions and products; and
developed public databases
that enable scientists to coordinate their
efforts in an enterprise that
has become one of the world's finest examples
of partnership among university-based
researchers, government, and private
industry.
Remarkable
as its achievements have been, the biotechnology enterprise
is still in its infancy.
We will reap even greater benefits as long as we
sustain the intellectual partnership
and public confidence that have moved
biotechnology forward thus
far. We must strengthen our efforts to improve
science education for all
Americans and preserve and promote the freedom of
scientific inquiry.
We must protect patients from the misuse or abuse of
sensitive medical information
and provide Federal regulatory agencies with
sufficient resources to maintain
sound, science-based review and regulation
of biotechnology products.
And we must strive to ensure that science-based
regulatory programs worldwide
promote public safety, earn public
confidence, and guarantee
fair and open international markets.
NOW,
THEREFORE, I, WILLIAM J. CLINTON, President of the United States
of America, by virtue of the
authority vested in me by the Constitution and
laws of the United States,
do hereby proclaim January 2000 as National
Biotechnology Month.
I call upon the people of the United States to
observe this month with appropriate
programs, ceremonies, and activities.
IN
WITNESS WHEREOF, I have hereunto set my hand this
nineteenth day of January,
in the year of our Lord two thousand, and of the
Independence of the United
States of America the two hundred and
twenty-fourth.
WILLIAM J. CLINTON
# # # |